We examined the effects of treatments with TGF-β1 PI polyamide on STZ-induced diabetic nephropathy and found that TGF-β1 PI polyamide effectively improved diabetic nephropathy including degeneration of the nephron tubules and glomeruli, and podocyte injury. This evidence concerns the gene TGFB1 and diabetic kidney disease.